Respiratory Compromise Institute

RSVP for this week's educational webinar with California Thoracic Society on Friday, August 22, 2025 at 5pm PT.⁣⁣
⁣⁣
𝐓𝐨𝐩𝐢𝐜: COPD with Type 2 Inflammation: A Spark for Deeper COPD Understanding⁣⁣
𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐞𝐫: Barry Make, MD⁣⁣
Co-Director, COPD Program; Professor of Medicine (Pulmonary), National Jewish Health, Denver, CO⁣⁣
Director, Pulmonary Rehabilitation, National Jewish Health, Denver, CO⁣⁣
⁣⁣
Click here to register: http://bit.ly/4lzUNLY⁣⁣
⁣⁣
This is a non-CME event.⁣⁣
Developed by the California Thoracic Society in collaboration with Regeneron.

Register to attend tomorrow's Zoom webinar at 5pm PT⁣⁣ on Exploring Asthma Triggers in SUA with Dr. Matthew Drake, MD, ATSF.

🎟️ https://bit.ly/cts-webinar-feb212025

This is a non-CME event.

Developed by the California Thoracic Society in collaboration with Amgen and AstraZeneca.

We invite you to watch the welcome speech delivered at RCI's Respiratory Compromise Conference. After the welcome intro, stay tuned for Dr. Wes Ely's virtual presentation on an insightful look at "Preventing Respiratory Catastrophe in the Hospital: Delirium, the 5th vital sign".

https://youtu.be/HWtSqnhLFqc

Join the California Thoracic Society and GSK via Zoom for their educational webinar & LIVE Q&A tonight @ 5pm PT.⁣⁣ 🔗 https://ow.ly/xHNY50TURQS

📚 Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation: Is it the Time for Precision Medicine in COPD?
🗣️ Nicola Hanania, MD, MS | Baylor College of Medicine Professor of Pulmonary Medicine, Director, Airways Clinical Research Center, Member, Vice Chair of Research Group

Q&A: There will be an opportunity for live Q&A at the conclusion of the formal presentation.

This is a non-CME event.

Developed by the California Thoracic Society in collaboration with GSK.

Join the California Thoracic Society and GSK for tomorrow night's educational webinar & LIVE Q&A on November 1st @ 5pm PT.⁣⁣ 🔗 https://ow.ly/xHNY50TURQS

📚 Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation: Is it the Time for Precision Medicine in COPD?
🗣️ Nicola Hanania, MD, MS | Baylor College of Medicine Professor of Pulmonary Medicine, Director, Airways Clinical Research Center, Member, Vice Chair of Research Group

Q&A: There will be an opportunity for live Q&A at the conclusion of the formal presentation.

This is a non-CME event.

Developed by the California Thoracic Society in collaboration with GSK.

"Almost all children get infected with respiratory syncytial virus (RSV) at least once before they are 2 years old. For most healthy children, RSV is like a cold. But some children get very sick with RSV."

New parents can take preventative measures before their newborn is brought into the world - They just have to know when and how.

Read more - https://www.healthychildren.org/English/health-issues/conditions/chest-lungs/Pages/RSV-When-Its-More-Than-Just-a-Cold.aspx

Please join the California Thoracic Society for a special educational webinar and LIVE Q&A on October 25th, at 5pm PT.⁣⁣
🔗 https://us06web.zoom.us/webinar/register/WN_hhguooORQa-AQ5WJtcqq4A

Topic: COPD with Type 2 Inflammation: A Spark For Deeper COPD Understanding
Speaker: Joseph E. Khabbaza, MD – Cleveland Clinic Foundation – Respiratory Institute
Q&A: There will be an opportunity for live Q&A at the conclusion of the formal presentation.

Developed by the California Thoracic Society in collaboration with Regeneron Pharmaceuticals Inc.

Explore new, advanced diagnostic software technologies during an educational webinar & LIVE Q&A with the California Thoracic Society:
🗓️ Friday, September 27th at 5pm PT.⁣
🔗 RSVP TODAY - https://bit.ly/3MLGa9K

Attendees will learn about highly detailed lung ventilation assessments and the precise quantification of lung volumes and other parameters, including areas of the lung with abnormal tissue density, that can provide actionable input for diagnoses.

Additionally, the session will demonstrate how to integrate these technologies to effectively triage patients presenting with unexplained dyspnea.

This is a non-CME event.

Developed by the California Thoracic Society in collaboration with 4DMedical.

The 3rd week of September is commonly referred to as "asthma peak week".

Here are some helpful tips the American Lung Association is sharing for parents to keep their children safe and healthy all year long.

Read more: https://www.lung.org/blog/asthma-back-to-school-tips

"AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy designed for quicker liberation from mechanical ventilation"

Read more: https://www.biospace.com/drug-development/lungpacer-medical-announces-pma-submission-for-aeropace-system

Inspira gains a new U.S. patent approval for their blood oxygenation system. The VORTX system is engineered to oxygenate blood without relying on fibre membranes.

Read more: https://www.medicaldevice-network.com/news/inspira-us-patent-blood-oxygenation/

"Climate change and air pollution negatively impact the health of patients with respiratory conditions – and yet some treatments used for those same conditions contribute to greenhouse gas emissions. Here, Dr David Lipson, GSK’s Vice President and Clinical Research Head, Respiratory and Immunology R&D, explains why a focus on sustainability in respiratory care is therefore essential – and how GSK is innovating to benefit both patients and the planet."

Read more: https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/